The hypothesis to be tested is whether treatment with intravenous iron (ferric
carboxymaltose) will improve left-ventricular ejection fraction in patients with heart
failure and iron deficiency as determined by cardiac magnetic resonance imaging.
Phase:
Phase 3
Details
Lead Sponsor:
University of Ulm
Collaborators:
RWTH Aachen University Universitätsklinikum Hamburg-Eppendorf